Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody-Reference-Cited by-同舟云学术

Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody

Published:2016-09 Issue:9 Volume:24 Page:1634-1643
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Seidel Ursula Jördis Eva,Schlegel Patrick,Grosse-Hovest Ludger,Hofmann Martin,Aulwurm Steffen,Pyz Elwira,Schuster Friedhelm R,Meisel Roland,Ebinger Martin,Feuchtinger Tobias,Teltschik Heiko-Manuel,Witte Kai-Erik,Schwarze Carl-Philipp,Rammensee Hans-Georg,Handgretinger Rupert,Jung Gundram,Lang Peter

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference48 articles.

1. Outcomes for children and adolescents with cancer: challenges for the twenty-first century;Smith;J Clin Oncol,2010

2. Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications;Hoffman;Front Oncol,2014

3. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95;Möricke;Blood,2008

4. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group;Bader;J Clin Oncol,2009

5. Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation;Lankester;Leukemia,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectors of the Future: Universal Chimeric Antigen Receptor;Transfusion Medicine and Hemotherapy;2024-07-15

2. Universal CAR 2.0 to overcome current limitations in CAR therapy;Frontiers in Immunology;2024-06-19

3. Immunocytokines with target cell–restricted IL-15 activity for treatment of B cell malignancies;Science Translational Medicine;2024-03-06

4. Tetraarsenic tetrasulfide triggers ROS-induced apoptosis and ferroptosis in B-cell acute lymphoblastic leukaemia by targeting HK2;Translational Oncology;2024-02

5. Highly-sensitive chimerism analysis in blood after allogeneic hematopoietic cell transplantation in childhood leukemia: Results from the Nordic Microchimerism Study;Frontiers in Hematology;2023-02-06